CCND1 and neoplasm: Our observations revealed that SOX17 overexpression correlated with reduced CyclinD1 and c-Myc levels, suggesting that SOX17 suppresses tumor growth through inhibition of β-catenin/TCF activity and the Wnt signaling pathway.